Genome Insight

La Jolla, United States

Genome Insight is a developer of a genome sequence (WGS) analysis and interpretation platform.

$23.0M raised

Nov 2023

Series B

Analytics Biotechnology Medical

Top Investors

InterVest Co.DSC InvestmentSchmidtSamsung Venture InvestmentMinistry of SMEs and Startups

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Genome Insight

How much funding has Genome Insight raised?

Genome Insight has raised $23.0M in total funding. The most recent round was Series B. The last funding was announced in November 2023.

Who are Genome Insight's investors?

Genome Insight's investors include InterVest Co., DSC Investment, Schmidt, Samsung Venture Investment, Ministry of SMEs and Startups.

Where is Genome Insight headquartered?

Genome Insight is headquartered in La Jolla, United States.

What does Genome Insight do?

Genome Insight is a developer of a genome sequence (WGS) analysis and interpretation platform.

What stage is Genome Insight at?

Genome Insight is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 1, 2023.

MLA

"Genome Insight — Funding & Investors." VCBacked, November 1, 2023, https://www.vcbacked.co/company/genome-insight. Accessed June 16, 2026.

APA

VCBacked. (2023). Genome Insight — Funding & Investors. Retrieved June 16, 2026, from https://www.vcbacked.co/company/genome-insight

Wikipedia (cite web)

{{cite web |title=Genome Insight — Funding & Investors |url=https://www.vcbacked.co/company/genome-insight |website=VCBacked |access-date=June 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 1, 2023.

Similar Companies in Analytics